3D Systems spins off new 3D bioprinting firm with goal of accelerating drug discovery R&D
US 3D printer manufacturer 3D Systems has announced the formation of a new 3D bioprinting subsidiary. Named Systemic Bio, the company is set to utilize the technologies developed as part of its parent firm’s Print to Perfusion program as well as those of its other subsidiary Allevi, to 3D bioprint vascularized organ models from human […]
Go to Source
Author: Paul Hanaphy
